Literature DB >> 23751132

Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [(123) I]-ADAM SPECT.

Jay D Amsterdam1, Andrew B Newberg, Cory F Newman, Justine Shults, Nancy Wintering, Irene Soeller.   

Abstract

Several studies have reported low brain serotonin transporter (SERT) binding in individuals with major depression. We hypothesized that the SERT standardized uptake ratio (SUR) values using [(123) I]-ADAM single photon emission computed tomography would increase in depressed subjects who responded to cognitive behavior therapy (CBT) compared to CBT nonresponders. [(123) I]-ADAM scans were acquired before and after 12 weeks of CBT from 20 depressed subjects and on two occasions 12 weeks apart from 10 nondepressed, healthy volunteers. The primary outcome measure was change over time in SUR values in the midbrain, medial temporal lobe, and basal ganglia regions. Depressed subjects demonstrated low pretreatment mean SUR values that significantly increased over time in the midbrain (P = .011), right medial temporal lobe (P = .008), and left medial temporal lobe (P = .000) regions. Treatment responders showed a significant increase over time in SUR values in left medial temporal lobe (P = .029) and right medial temporal lobe (P = .007) regions. Partial and nonresponder subjects also showed a significant increase over time in SUR values in the left medial temporal region (P = .040) (vs. healthy volunteers), but to a lesser degree. The findings suggest that low pretreatment SERT binding may increase over time in some depressed individuals who experience symptom improvement.
Copyright © 2013 by the American Society of Neuroimaging.

Entities:  

Keywords:  SPECT; depression; serotonin transporter; treatment

Mesh:

Substances:

Year:  2013        PMID: 23751132      PMCID: PMC4592779          DOI: 10.1111/jon.12035

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  34 in total

1.  Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings.

Authors:  S D Martin; E Martin; S S Rai; M A Richardson; R Royall
Journal:  Arch Gen Psychiatry       Date:  2001-07

2.  Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.

Authors:  A L Brody; S Saxena; P Stoessel; L A Gillies; L A Fairbanks; S Alborzian; M E Phelps; S C Huang; H M Wu; M L Ho; M K Ho; S C Au; K Maidment; L R Baxter
Journal:  Arch Gen Psychiatry       Date:  2001-07

3.  Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study.

Authors:  Pei Chun Hsieh; I Hui Lee; Tzung Lieh Yeh; Kao Chin Chen; Hui Chun Huang; Po See Chen; Yen Kuang Yang; Wei Jen Yao; Ru-Band Lu; Nan Tsing Chiu
Journal:  Psychiatry Res       Date:  2010-10-27       Impact factor: 3.222

4.  Cerebral serotonin transporter binding is inversely related to body mass index.

Authors:  D Erritzoe; V G Frokjaer; M T Haahr; J Kalbitzer; C Svarer; K K Holst; D L Hansen; T L Jernigan; S Lehel; G M Knudsen
Journal:  Neuroimage       Date:  2010-04-09       Impact factor: 6.556

5.  Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes.

Authors:  Jan Kalbitzer; David Erritzoe; Klaus K Holst; Finn A Nielsen; Lisbeth Marner; Szabolcs Lehel; Tine Arentzen; Terry L Jernigan; Gitte M Knudsen
Journal:  Biol Psychiatry       Date:  2010-01-27       Impact factor: 13.382

6.  Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression.

Authors:  Mikko Joensuu; Soili Marianne Lehto; Tommi Tolmunen; Pirjo Irmeli Saarinen; Minna Valkonen-Korhonen; Ritva Vanninen; Pasi Ahola; Jari Tiihonen; Jyrki Kuikka; Ullamari Pesonen; Johannes Lehtonen
Journal:  Psychiatry Clin Neurosci       Date:  2010-08       Impact factor: 5.188

7.  [123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.

Authors:  M Willeit; N Praschak-Rieder; A Neumeister; W Pirker; S Asenbaum; O Vitouch; J Tauscher; E Hilger; J Stastny; T Brücke; S Kasper
Journal:  Biol Psychiatry       Date:  2000-03-15       Impact factor: 13.382

8.  Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.

Authors:  P D Acton; S R Choi; C Hou; K Plössl; H F Kung
Journal:  J Nucl Med       Date:  2001-10       Impact factor: 10.057

9.  Low brain serotonin transporter binding in major depressive disorder.

Authors:  Andrew B Newberg; Jay D Amsterdam; Nancy Wintering; Justine Shults
Journal:  Psychiatry Res       Date:  2012-06-12       Impact factor: 3.222

10.  Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome.

Authors:  J D Lundgren; J Amsterdam; A Newberg; K C Allison; N Wintering; A J Stunkard
Journal:  Eat Weight Disord       Date:  2009-03       Impact factor: 4.652

View more
  9 in total

Review 1.  The neuroscience of depression: implications for assessment and intervention.

Authors:  Manpreet K Singh; Ian H Gotlib
Journal:  Behav Res Ther       Date:  2014-09-04

2.  Association Study of the Beta-Adrenergic Receptor Genetic Variant Gly389Arg and Fluoxetine Response in Major Depression.

Authors:  Negar Firouzabadi; Roja Asadpour; Kamiar Zomorrodian
Journal:  Galen Med J       Date:  2020-03-05

Review 3.  Radiotracers for the Central Serotoninergic System.

Authors:  Reynald Mangeant; Emmanuelle Dubost; Thomas Cailly; Valérie Collot
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-03

Review 4.  Neuroimaging for psychotherapy research: current trends.

Authors:  Carol P Weingarten; Timothy J Strauman
Journal:  Psychother Res       Date:  2014-02-17

5.  Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies.

Authors:  Margaret T Davis; Sophie E Holmes; Robert H Pietrzak; Irina Esterlis
Journal:  Chronic Stress (Thousand Oaks)       Date:  2017-06-22

Review 6.  Disentangling the Neural Basis of Cognitive Behavioral Therapy in Psychiatric Disorders: A Focus on Depression.

Authors:  Moussa A Chalah; Samar S Ayache
Journal:  Brain Sci       Date:  2018-08-09

7.  Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy.

Authors:  Olof Hjorth; Andreas Frick; Malin Gingnell; Jonas Engman; Johannes Björkstrand; Vanda Faria; Iman Alaie; Per Carlbring; Gerhard Andersson; My Jonasson; Mark Lubberink; Gunnar Antoni; Margareta Reis; Kurt Wahlstedt; Mats Fredrikson; Tomas Furmark
Journal:  Transl Psychiatry       Date:  2022-10-07       Impact factor: 7.989

8.  Serotonin transporter regulation by cholesterol-independent lipid signaling.

Authors:  Carmen M Deveau; Eric Rodriguez; Allen Schroering; Bryan K Yamamoto
Journal:  Biochem Pharmacol       Date:  2020-11-25       Impact factor: 5.858

Review 9.  Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder.

Authors:  Seung-Gul Kang; Seo-Eun Cho
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.